Amato, M. P., Langdon, D., Montalban, X., Benedict, R. H., DeLuca, J., Krupp, L. B., Thompson, A. J. & Comi, G. (2013). Treatment of cognitive impairment in multiple sclerosis: Position paper. Journal of Neurology, 260(6), 1452-68.
Amato, M. P., Portaccio, E., Goretti, B., Zipoli, V., Iudice, A., Pina, D. D., Malentacchi, G., Sabatini, S., Annunziata, P., Falcini, M., Mazzoni, M., Mortilla, M., Fonda, C. & De Stefano, N. (2010). Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study. Multiple Sclerosis Journal, 16(12), 1474-1482.
Benedict, R. H., Cookfair, D., Gavett, R., Gunther, M., Munschauer, F., Garg, N. & Weinstock-Guttman, B. (2006). Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). Journal of the International Neuropsychological Society, 12(4), 549-58.
Bilgi, E., Özdemir, H. H. & Bulut, S. (2013). Determining the Frequency of Depression and Cognitive Dysfunction in Patients with Multiple Sclerosis. Turkish Journal of Neurology, 19, 11-4.
Boeschoten, R. E., Braamse, A. M., Beekman, A. T., Cuijpers, P., Van Oppen, P., Dekker, J. & Uitdehaag, B. M. J. (2017). Prevalence of depression and anxiety in Multiple Sclerosis: A systematic review and meta-analysis. Journal of the Neurological Sciences, 372, 331-341.
Borghi, M., Carletto, S., Ostacoli, L., Scavelli, F., Pia, L., Pagani, M., Bertolotto, A., Malucchi, S., Signori, A. & Cavallo, M. (2016). Decline of neuropsychological abilities in a large sample of patients with multiple sclerosis: A two-year longitudinal study. Frontiers in Human Neuroscience, 10, 282.
Boringa, J. B., Lazeron, R. H., Reuling, I. E., Ader, H. J., Pfennings, L. E., Lindeboom, J., De Sonneville, L. MJ., Kalkes, N. F. & Polman, C. H. (2001). The brief repeatable battery of neuropsychological tests: normative values allow application in multiple sclerosis clinical practice. Multiple Sclerosis Journal, 7, 263-267.
Campbell, J., Rashid, W., Cercignani, M. & Langdon, D. (2016). Cognitive impairment among patients with multiple sclerosis: associations with employment and quality of life. Postgraduate Medical Journal, 1-5.
Chiaravalloti, N. D. & DeLuca, J. (2008). Cognitive impairment in multiple sclerosis. The lancet. Neurology, 7(12), 1139.
Chwastiak, L., Ehde, D. M., Gibbons, L. E., Sullivan, M., Bowen, J. & Kraft, G.H. (2002). Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample. The American Journal of Psychiatry, 159, 1862-1868.
Ehrenreich, J. H. (1995). Normative data for adults on a short from of The Selective Reminding Test. Psychological Reports, 76, 387-390.
Emre, U., Ergün, U., Yıldız, H., Coşkun, Ö. & İnan, L. E. (2003). Multipl sklerozda depresyon. Düşünen Adam, 16(1), 53-56.
Giardono, A. (2011). Anxiety and depression in multiple sclerosis patients around diagnosis. Journal of the Neuroligical Sciences, 307, 86-91.
Glanz, B. I., Holland, C. M., Gauthier, S.A., Amunwa, E. L., Liptak, Z., Houtchens, M. K., Sperling, R. A., Khoury, S. J., Guttmann, C. R. G. & Weiner, H. L. (2007). Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis. Multiple Sclerosis Journal, 13(8), 1004-10.
Institute for Health Metrics and Evaluation (2019). Global Burden of Disease Study 2019 (GBD 2019) Data Resources| GHDx.
Keklikoğlu, H. D., Yoldaş, T. K., Zengin, Ö., Banu Solak, E. & Keskin, S. (2010). Erken dönem Relapsing-Remitting multipl skleroz hastalarında bilişsel işlev bozuklukları. Nöropsikiyatri Arşivi, 47, 88- 90.
Kister, I., Bacon, T. E., Chamot, E., Salter, A. R., Cutter, G. R., Kalina, J. T. & Herbert, J. (2013). Natural history of multiple sclerosis symptoms. International Journal of MS Care, 15, 146-156.
López-Góngora, M., Querol, L. & Escartín, A. (2015). A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity. BMC Neurology, 15(1), 1-8.
Lovibond, P. F., & Lovibond, S. H. (1995). The structure of negative emotional states: Comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behavior Research and Therapy, 33(3), 335-343.
Migliore, S., Ghazaryan, A., Simonelli, I., Pasqualetti, P., Squitieri, F., Curcio, G., Landi, D., Palmieri, G., Moffa, F., Filippi, M. M. & Vernieri, F. (2017). Cognitive impairment in relapsing remitting multiple sclerosis patients with very mild clinical disability. Behavioral Neurology, Article ID 7404289.
Oh, J., Vidal-Jordana, A., & Montalban, X. (2018). Multiple sclerosis: Clinical aspects. Current Opinion in Neurology, 31, 752-759.
Patten, S. B., Fridhandler, S., Beck, C. A. & Metz, L. M. (2003). Depressive symptoms in a treated multiple sclerosis cohort. Multiple Sclerosis Journal, 9, 616-620.
Rao S. M., Leo, G. J., Bernardin, L. & Unverzagt, F. (1991). Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology, 41(5), 685–691.
Romero, K., Shammi, P. & Feinstein, A. (2015). Neurologists' accuracy in predicting cognitive impairment in multiple sclerosis. Multiple Sclerosis and Related Disorders, 4, 291–295.
Sarıçam H. (2018). The psychometric properties of Turkish version of Depression Anxiety Stress Scale-21 (DASS-21) in health control and clinical samples. Journal of Cognitive Behavioral Psychotherapy and Research, 7(1), 19-30.
Sepulcre, J., Vanotti, S., Hernández, R., Sandoval, G., Cáceres, F., Garcea, O. & Villoslada, P. (2016). Cognitive impairment in patients with multiple sclerosis using the Brief Repeatable Battery-Neuropsychology test. Multiple Sclerosis Journal, 12(2), 187-195.
Şen, N., Genç, Ş. G., Aydın, N. K., Kılınçel, O., Altınışık, İ., Kılınçel, Ş., Köle, İ. H., & Eker, S. S. (2015). Multiple sklerozda depresyon ve anksiyete. Uludağ Üniversitesi Tıp Fakültesi Dergisi, 41(2), 73-77.
Tettenborn, B., Yıldız, M., Radue, E. W., Bendfeldt, K. & Borgwardt, S. (2014). Clinical Neurology and Neurosurgery, 12, 54–58.
Thompson, A. J., Banwell, B. L., Barkhof, F., Carroll, W. M., Coetzee, T., Comi, G. & Cohen, J. A. (2018). Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. The Lancet Neurology, 17(2), 162-173.
Topçular, B., Özcan, M. E., Kurt, E., Yandım Kuşçu, D., Kale İçen, N. & Sütlaş, P. (2012). Yineleyici Multipl Skleroz’da kognitif bozukluk. Archives of Neuropsychiatry, 49, 178-182.